Artivion has been granted a patent for an expandable vascular implant designed for vessel implantation in patients. The implant can transition from a compressed to an expanded state, featuring a unique tubular lattice structure with self-expandable and balloon-dilatable regions, along with a radiopaque marker for visibility. GlobalData’s report on Artivion gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Artivion Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Artivion, Prosthetic cardiac valves was a key innovation area identified from patents. Artivion's grant share as of January 2024 was 59%. Grant share is based on the ratio of number of grants to total number of patents.

Expandable vascular implant for patient vessels with self-expandable and balloon-dilatable regions

Source: United States Patent and Trademark Office (USPTO). Credit: Artivion Inc

A recently granted patent (Publication Number: US11844680B2) discloses an expandable vascular implant designed for implantation into a patient's vessels. The implant can transition from a compressed state to an expanded state and consists of a hollow cylindrical main body formed by a tubular lattice structure. This lattice structure includes different materials in distinct regions - a self-expandable first region made of stent springs and a balloon-dilatable second region constructed from a mesh with filamentary elements. The implant also features a marker containing a radiopaque material for enhanced visibility during procedures.

The patent further details an insertion system for deploying the vascular implant, comprising a retraction sheath for compression, and a catheter with a dilation body. The method for delivering and releasing the implant involves loading it into the insertion system, inserting it into the target vessel, and releasing it by dilating the dilation body and retracting the sheath. The patent also specifies variations in materials, diameters, and lengths of the implant, catering to different patient needs and vessel sizes. Overall, the patent aims to provide an innovative solution for treating vasoconstriction or vessel ruptures effectively and efficiently.

To know more about GlobalData’s detailed insights on Artivion, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.